首页> 美国卫生研究院文献>Internal Medicine >Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review
【2h】

Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review

机译:晚期肺腺癌患者因Nivolumab引起的垂体炎而孤立的肾上腺皮质激素缺乏症:病例报告和文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 63-year-old Japanese woman with advanced lung adenocarcinoma developed isolated adrenocorticotropin deficiency caused by immune checkpoint inhibitor (ICI)-related hypophysitis following 8 months of nivolumab therapy. Prompt corticosteroid replacement therapy effectively relieved her secondary adrenal insufficiency symptoms and allowed her to pursue nivolumab therapy, which had been effective for the control of lung adenocarcinoma. Human leukocyte antigen (HLA) typing revealed the presence of the DRB1*04:05-DQA1*03:03-DQB1*04:01 haplotype, which is associated with susceptibility to autoimmune polyglandular syndrome with pituitary disorder in the Japanese population. This case suggests that genetic factors, such as HLA, contribute to the development of endocrinopathies induced by ICIs.
机译:一名63岁的日本女性患有晚期肺腺癌,在接受nivolumab治疗8个月后,出现了由免疫检查点抑制剂(ICI)相关垂体引起的孤立性肾上腺皮质激素缺乏症。及时的皮质类固醇替代疗法可有效缓解她的继发性肾上腺功能不全症状,并允许她继续进行nivolumab治疗,该方法已有效控制了肺腺癌。人类白细胞抗原(HLA)分型揭示了DRB1 * 04:05-DQA1 * 03:03-DQB1 * 04:01单倍型的存在,这与日本人群对垂体疾病的自身免疫性多腺综合征的易感性有关。这种情况表明,遗传因素(例如HLA)有助于由ICI诱导的内分泌病变的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号